Bisoprolol (bisoprolol fumarate) NDC 42571-471

NDC codes

FDA NDC Directory

Product NDC (as listed)42571-471Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42571-0471Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
42571-471-01	42571047101	100 TABLET, FILM COATED in 1 BOTTLE (42571-471-01)Marketed from Jun 1, 2026
42571-471-05	42571047105	500 TABLET, FILM COATED in 1 BOTTLE (42571-471-05)Marketed from Jun 1, 2026
42571-471-30	42571047130	30 TABLET, FILM COATED in 1 BOTTLE (42571-471-30)Marketed from Jun 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Bisoprolol
Generic name (nonproprietary): bisoprolol fumarate
Active ingredients: Bisoprolol fumarate — 10 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Micro Labs Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218303
Marketing start: Jun 1, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)
Identifiers: Product ID 42571-471_4cbe74e3-3af3-2b98-e063-6294a90a1c2bSPL ID 4cbe74e3-3af3-2b98-e063-6294a90a1c2bSPL set ID c3ee566c-74c4-45f4-a947-526a7313e326RxCUI 854901, 854905UNII UR59KN573LUPC 0342571470302, 0342571471309
Pharmacologic class: beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442571047101 followed by a unit qualifier and the quantity

Package 42571-0471-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 11, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Bisoprolol fumarate tablets are indicated in the management of hypertension. It may be used alone or in combination with other antihypertensive agents.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 218303

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218303
Product	Strength	Form · route	Labeler	Product NDC
Bisoprololbisoprolol fumarate	Bisoprolol fumarate 5 mg/1	Tablet, Film coatedOral	Micro Labs Limited	42571-470